2022 NBI listing additions and deletions:
Nasdaq (Nasdaq: NDAQ) today announced the results of the annual reconstitution of the Nasdaq Biotechnology Index (Nasdaq: NBI), which will become effective prior to market open on Monday, December 20, 2021.
The Index is designed to track the performance of a set of securities listed on The Nasdaq Stock Market® (Nasdaq®) that are classified as either biotechnology or pharmaceutical according to the Industry Classification Benchmark (ICB).
The following 129 securities will be added to the Index:
Exchange
| Ticker
| Company
| Nasdaq
| BTX
| Brooklyn ImmunoTherapeutics, Inc.
| Nasdaq
| LXRX
| Lexicon Pharmaceuticals, Inc.
| Nasdaq
| CRIS
| Curis, Inc.
| Nasdaq
| HBIO
| Harvard Bioscience, Inc.
| Nasdaq
| EYPT
| EyePoint Pharmaceuticals, Inc.
| Nasdaq
| MTEM
| Molecular Templates, Inc.
| Nasdaq
| VIRX
| Viracta Therapeutics, Inc.
| Nasdaq
| AVXL
| Anavex Life Sciences Corp.
| Nasdaq
| INFI
| Infinity Pharmaceuticals, Inc.
| Nasdaq
| HROW
| Harrow Health, Inc.
| Nasdaq
| TNXP
| Tonix Pharmaceuticals Holding Corp.
| Nasdaq
| CMRX
| Chimerix, Inc.
| Nasdaq
| ADMA
| ADMA Biologics Inc
| Nasdaq
| SESN
| Sesen Bio, Inc.
| Nasdaq
| CLSD
| Clearside Biomedical, Inc.
| Nasdaq
| PRQR
| ProQR Therapeutics N.V.
| Nasdaq
| ALPN
| Alpine Immune Sciences, Inc.
| Nasdaq
| ACRS
| Aclaris Therapeutics, Inc.
| Nasdaq
| NVCR
| NovoCure Limited
| Nasdaq
| MRUS
| Merus N.V.
| Nasdaq
| OCX
| Oncocyte Corporation
| Nasdaq
| CRVS
| Corvus Pharmaceuticals, Inc.
| Nasdaq
| LPTX
| Leap Therapeutics, Inc.
| Nasdaq
| OBSV
| ObsEva SA
| Nasdaq
| MBIO
| Mustang Bio, Inc.
| Nasdaq
| OPTN
| OptiNose, Inc.
| Nasdaq
| SLDB
| Solid Biosciences Inc.
| Nasdaq
| NRXP
| NRX Pharmaceuticals, Inc.
| Nasdaq
| EOLS
| Evolus, Inc.
| Nasdaq
| COGT
| Cogent Biosciences, Inc.
| Nasdaq
| MREO
| Mereo BioPharma Group plc
| Nasdaq
| AQST
| Aquestive Therapeutics, Inc.
| Nasdaq
| EVLO
| Evelo Biosciences, Inc.
| Nasdaq
| VRCA
| Verrica Pharmaceuticals Inc.
| Nasdaq
| GRTS
| Gritstone bio, Inc.
| Nasdaq
| INBX
| Inhibrx, Inc.
| Nasdaq
| BCYC
| Bicycle Therapeutics plc
| Nasdaq
| CDAK
| Codiak BioSciences, Inc.
| Nasdaq
| MIRM
| Mirum Pharmaceuticals, Inc.
| Nasdaq
| IMPL
| Impel NeuroPharma, Inc.
| Nasdaq
| MORF
| Morphic Holding, Inc.
| Nasdaq
| OYST
| Oyster Point Pharma, Inc.
| Nasdaq
| ETNB
| 89bio, Inc.
| Nasdaq
| PHAT
| Phathom Pharmaceuticals, Inc.
| Nasdaq
| FDMT
| 4D Molecular Therapeutics, Inc.
| Nasdaq
| CVAC
| CureVac N.V.
| Nasdaq
| HRMY
| Harmony Biosciences Holdings, Inc.
| Nasdaq
| VTRS
| Viatris Inc.
| Nasdaq
| QSI
| Quantum-Si Incorporated
| Nasdaq
| PMVP
| PMV Pharmaceuticals, Inc.
| Nasdaq
| KYMR
| Kymera Therapeutics, Inc.
| Nasdaq
| NAUT
| Nautilus Biotechnology, Inc.
| Nasdaq
| DYN
| Dyne Therapeutics, Inc.
| Nasdaq
| CCCC
| C4 Therapeutics, Inc.
| Nasdaq
| HUMA
| Humacyte, Inc.
| Nasdaq
| ATHA
| Athira Pharma, Inc.
| Nasdaq
| LABP
| Landos Biopharma, Inc.
| Nasdaq
| TSHA
| Taysha Gene Therapies, Inc.
| Nasdaq
| ONCR
| Oncorus, Inc.
| Nasdaq
| PRAX
| Praxis Precision Medicines, Inc.
| Nasdaq
| CMPS
| COMPASS Pathways Plc
| Nasdaq
| PRLD
| Prelude Therapeutics Incorporated
| Nasdaq
| BOLT
| Bolt Biotherapeutics, Inc.
| Nasdaq
| ABCM
| Abcam plc
| Nasdaq
| STTK
| Shattuck Labs, Inc.
| Nasdaq
| KRON
| Kronos Bio, Inc.
| Nasdaq
| ALGS
| Aligos Therapeutics, Inc.
| Nasdaq
| AVIR
| Atea Pharmaceuticals, Inc.
| Nasdaq
| OLMA
| Olema Pharmaceuticals, Inc.
| Nasdaq
| SBTX
| Silverback Therapeutics, Inc.
| Nasdaq
| MRVI
| Maravai LifeSciences Holdings, Inc.
| Nasdaq
| BCAB
| BioAtla, Inc.
| Nasdaq
| GRCL
| Gracell Biotechnologies Inc.
| Nasdaq
| KNTE
| Kinnate Biopharma Inc.
| Nasdaq
| SEER
| Seer, Inc.
| Nasdaq
| ME
| 23andMe Holding Co.
| Nasdaq
| KMPH
| KemPharm, Inc.
| Nasdaq
| BVS
| Bioventus Inc.
| Nasdaq
| SNSE
| Sensei Biotherapeutics, Inc.
| Nasdaq
| SABS
| SAB Biotherapeutics, Inc.
| Nasdaq
| VOR
| Vor Biopharma Inc.
| Nasdaq
| ABCL
| AbCellera Biologics Inc.
| Nasdaq
| CGEM
| Cullinan Oncology, Inc.
| Nasdaq
| DBTX
| Decibel Therapeutics, Inc.
| Nasdaq
| CNTB
| Connect Biopharma Holdings Limited
| Nasdaq
| SANA
| Sana Biotechnology, Inc.
| Nasdaq
| ACHL
| Achilles Therapeutics plc
| Nasdaq
| IKNA
| Ikena Oncology, Inc.
| Nasdaq
| TERN
| Terns Pharmaceuticals, Inc.
| Nasdaq
| EWTX
| Edgewise Therapeutics, Inc.
| Nasdaq
| RXRX
| Recursion Pharmaceuticals, Inc.
| Nasdaq
| RXDX
| Prometheus Biosciences, Inc.
| Nasdaq
| TIL
| Instil Bio, Inc.
| Nasdaq
| DSGN
| Design Therapeutics, Inc.
| Nasdaq
| BMEA
| Biomea Fusion, Inc.
| Nasdaq
| RAIN
| Rain Therapeutics Inc.
| Nasdaq
| ATAI
| ATAI Life Sciences N.V.
| Nasdaq
| CADL
| Candel Therapeutics, Inc.
| Nasdaq
| HOWL
| Werewolf Therapeutics, Inc.
| Nasdaq
| TALS
| Talaris Therapeutics, Inc.
| Nasdaq
| CYT
| Cyteir Therapeutics, Inc.
| Nasdaq
| OMIC
| Singular Genomics Systems, Inc.
| Nasdaq
| DNAY
| Codex DNA, Inc.
| Nasdaq
| CNTA
| Centessa Pharmaceuticals plc
| Nasdaq
| IMGO
| Imago BioSciences, Inc.
| Nasdaq
| IPSC
| Century Therapeutics, Inc.
| Nasdaq
| SERA
| Sera Prognostics, Inc.
| Nasdaq
| RANI
| Rani Therapeutics Holdings, Inc.
| Nasdaq
| VERV
| Verve Therapeutics, Inc.
| Nasdaq
| DAWN
| Day One Biopharmaceuticals, Inc.
| Nasdaq
| JANX
| Janux Therapeutics, Inc.
| Nasdaq
| TKNO
| Alpha Teknova, Inc.
| Nasdaq
| GLUE
| Monte Rosa Therapeutics, Inc.
| Nasdaq
| RPID
| Rapid Micro Biosystems, Inc.
| Nasdaq
| AVTE
| Aerovate Therapeutics, Inc.
| Nasdaq
| ERAS
| Erasca, Inc.
| Nasdaq
| TNYA
| Tenaya Therapeutics, Inc.
| Nasdaq
| ICVX
| Icosavax, Inc.
| Nasdaq
| IMRX
| Immuneering Corporation
| Nasdaq
| RLYB
| Rallybio Corporation
| Nasdaq
| GRPH
| Graphite Bio, Inc.
| Nasdaq
| ABOS
| Acumen Pharmaceuticals, Inc.
| Nasdaq
| LYEL
| Lyell Immunopharma, Inc.
| Nasdaq
| ABSI
| Absci Corporation
| Nasdaq
| NUVL
| Nuvalent, Inc.
| Nasdaq
| OMGA
| Omega Therapeutics, Inc.
| Nasdaq
| CRBU
| Caribou Biosciences, Inc.
| Nasdaq
| MXCT
| MaxCyte, Inc.
| Nasdaq
| BLU
| BELLUS Health Inc.
|
As a result of the reconstitution, the following 21 securities will be removed from the Index:
Exchange
| Ticker
| Company
| Nasdaq
| MNOV
| MediciNova, Inc.
| Nasdaq
| ASMB
| Assembly Biosciences, Inc.
| Nasdaq
| CNCE
| Concert Pharmaceuticals, Inc.
| Nasdaq
| ARDX
| Ardelyx, Inc.
| Nasdaq
| CALA
| Calithera Biosciences, Inc.
| Nasdaq
| XBIT
| XBiotech Inc.
| Nasdaq
| KALA
| Kala Pharmaceuticals, Inc.
| Nasdaq
| VYGR
| Voyager Therapeutics, Inc.
| Nasdaq
| ODT
| Odonate Therapeutics, Inc.
| Nasdaq
| VYNE
| VYNE Therapeutics Inc.
| Nasdaq
| UBX
| Unity Biotechnology, Inc.
| Nasdaq
| OSMT
| Osmotica Pharmaceuticals plc
| Nasdaq
| ORTX
| Orchard Therapeutics plc
| Nasdaq
| KLDO
| Kaleido Biosciences, Inc.
| Nasdaq
| BCEL
| Atreca, Inc.
| Nasdaq
| APRE
| Aprea Therapeutics, Inc.
| Nasdaq
| FUSN
| Fusion Pharmaceuticals Inc.
| Nasdaq
| INZY
| Inozyme Pharma, Inc.
| Nasdaq
| TSVTV
| 2seventy bio, Inc.
| Nasdaq
| ANIP
| ANI Pharmaceuticals, Inc.
| Nasdaq
| DRNA
| Dicerna Pharmaceuticals,
|
|
